## diﬀerently. In one-on-one meetings with individual board members of

GSK, he stressed the company’s moral responsibility to alleviate human

suﬀering and tied it to the long-term success of the company. He stated

that GSK can’t make medicines that save lives and then not allow people

access to them. He noted the public relations disaster associated with

the lawsuit, and set forth a vision, co-created by his team, for how GSK

could also become a leader in the ﬁght against TB and malaria, diseases

that also were disproportionately impacting third-world populations.

The external pressure did not abate, with protests against many drug